Health AI Central
Share:
Peer-Reviewed Publication
Eur J Breast Health2026;22(3):3.July 1, 2026Conference Proceedings

Cancer Genetic Risk Assessment (CGRA) Certification: Outcomes from the First Six Years.

Edith Smith1,2, Kimberly Samuels-Bolin1, Kristie Bobolis1,3
1National Consortium of Breast Centers, Indiana, USA.
2Myriad Genetics, Inc., Utah, USA.
3Sutter Medical Group, California, USA.
PubMed

Abstract

OBJECTIVE: Integrating cancer genetics, genomics and cancer risk assessment is increasingly relevant to the care of patients and there is a need for clinicians across practice disciplines to acquire and demonstrate knowledge and clinical competency in cancer genetics and cancer risk assessment. National Consortium of Breast Centers (NCBC's) certification program in Cancer Genetic Risk Assessment (…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.